Stantec (TSX:STN) Stock: Is it Worth Buying Before June?

Stantec Inc. (TSX:STN) stock still looks undervalued in a choppy market after the release of its first-quarter 2022 earnings.

| More on:
Question marks in a pile

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

Stantec (TSX:STN)(NYSE:STN) is an Edmonton-based company that provides engineering, architecture, and environmental consulting services in spaces like infrastructure and facilities in North America and around the world. Investors have been put in a tough spot, as volatility has reared its head in the spring of 2022. There is a good chance we will see more turbulence, as policymakers look to combat runaway inflation.

Today, I want to discuss whether this interesting stock is worth snatching up on the dip in this environment. Let’s jump in.

How has Stantec performed in 2022?

This Canadian stock had fallen into a rough patch in the later winter of 2022. Stantec stock has dropped 20% in 2022 as of close on March 24. The stock is still up 2.9% in the year-over-year period.

This company offers exposure to a variety of sectors that include engineering, architecture, and the environmental space through its consulting services. Meanwhile, the management consulting market is geared up for strong growth in the years ahead. Market researcher Mordor Intelligence recently projected that the consulting service market will post a CAGR of 4.3% from 2021 through to 2026.

Should investors be encouraged by its recent quarterly report?

The company released its first-quarter 2022 results on May 11. There were many positives to glean from Stantec as it opened the new fiscal year. It reported net revenue of $171 million — up 19% from the previous year. That increase was powered by 6.4% organic growth and 13% acquisition net revenue growth. It posted growth in all segments.

Stantec delivered adjusted net income growth of 21% to $68.4 million while adjusted diluted earnings per share climbed 22% to $0.61. The company’s bottom line was bolstered by recent acquisitions and a lower income tax expense. Stantec’s Contract Backlog was reported at $5.4 billion as at March 31, 2022. This represented a new record for the company and organic growth of 6.8%. It continued to deliver organic backlog growth across its segments.

Adjusted EBITDA rose to $152 million in the first quarter of 2022 compared to $129 million in the previous year. Meanwhile, the company reaffirmed its guidance for the full year. Moreover, Stantec is in a good position to benefit from strengthening local supply chains across a variety of key sectors.

Is Stantec a buy in late May?

Shares of Stantec reached an all-time high of $73.10 in late 2021. Meanwhile, the stock currently possesses a price-to-earnings ratio of 32. That puts this Canadian stock in solid value territory compared to its industry peers. The stock last had an RSI of 44, as it has climbed out of technically oversold levels since the middle of May.

In its Q1 2022 report, Stantec’s board of directors announced a quarterly dividend of $0.18 per share. That represents a modest 1.2% yield. This Canadian stock is well positioned for strong earnings growth in the quarters ahead. Better yet, it still offers nice value at the time of this writing. I’m looking to snatch up Stantec in late May.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Ambrose O'Callaghan has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

More on Investing

Workers use a microscope to do medical research in a modern laboratory.
Investing

Is Now the Time to Buy Health Care Stocks?

Health care stocks are on the up, but does that mean you should go ahead and buy anything? In short:…

Read more »

Volatile market, stock volatility
Investing

2 Volatile Stocks to Hold for a Decade

The market is full of opportunities for investors. But does that opportunity include some volatile stocks to hold?

Read more »

Arrowings ascending on a chalkboard
Investing

1 Under-the-Radar U.S. Stock to Buy in August

Canadians on the hunt for an undervalued and under-the-radar U.S. stock should consider Match Group Inc.

Read more »

Woman has an idea
Dividend Stocks

2 Low-Risk Growth Stocks Paying Great Dividends

These top TSX dividend stocks give investors exposure to interesting growth opportunities.

Read more »

A person builds a rock tower on a beach.
Dividend Stocks

Got $300? 2 Simple TSX Stocks to Buy Right Now

These two simple TSX stocks have everything a long-term investor looking to dollar cost average into a position wants right…

Read more »

A golden egg in a nest
Dividend Stocks

Millennials: No Excuses! Start Saving for Retirement Right Now.

Millennials, we need to stop complaining and start bragging. We're great savers, so it's time to start investing in TSX…

Read more »

Value for money
Dividend Stocks

3 UNDERVALUED TSX Stocks to Buy in August

Here are some attractively valued TSX stocks for the long term.

Read more »

A young man throwing and catching his daughter above his head
Dividend Stocks

Parents: Double Your CCB Payments This Month!

Parents can use those CCB payments to their benefit and double them this year month after month -- no waiting,…

Read more »